How Low Can Walgreens Boots Alliance Stock Go? | The Motley Fool (2024)

Walgreens stock can't seem to get out of its tailspin.

Sometimes it can seem like a stock is a falling knife, where trying to slow its fall is just going to cut you. That's what Walgreens Boots Alliance (WBA 0.65%) investors may be feeling right now. The stock has dropped to levels it hasn't traded at since the 1990s, and it keeps falling lower. The price drop suggests that the market knows that Walgreens faces a tough road ahead.

Walgreens is working to regain the market's confidence. With a new CEO, there's some hope that things could get better for the business. All indications, though, suggest it will take a while before that happens. But how low could the stock go till then?

Are investors better off selling their shares in this struggling retailer, or is it a better move to simply hang on and wait at this point?

Where analysts see the stock going

Analysts take on the task of researching a stock in detail to give their clients (and sometimes the general public) an informed evaluation of how much (if any) potential there is for the stock to perform. When an analyst sets a price target, it typically covers a period of 12 months or so. Based on the consensus analyst price target of $23.57 as of June 10, Walgreens shares could rise by nearly 50% over the next 12 months from where they trade today.

But before you rush out and buy the stock based on that forecast, it's important to remember that analysts routinely update their price targets. And the last five analysts covering this stock who set price targets have lowered them. As that continues to happen, the consensus average will come down. What remains encouraging is that four of the past five targets are still higher than where the stock trades right now, so even despite the downgrades, analysts still believe the stock should be worth more in the near term.

What does Walgreens' valuation say about the stock?

While analyst price targets can be helpful when gauging a stock's potential, it's always important to do an independent evaluation. This can be done by looking at earnings and book multiples. Currently, Walgreens trades at just 5 times its estimated future earnings and right around its book value.

That seems cheap, but let's consider a bit more context. For one thing, Walgreens has struggled with profitability. In each of the past four quarters, it incurred an operating loss. This has been a low-margin business and that isn't likely to change, especially as it focuses on launching health clinics -- a venture that even low-cost leader Walmart doesn't appear to think is worth the effort. While opening health clinics may present Walgreens with a new growth opportunity, it may not necessarily be a hugely profitable one.

Based on earnings, Walgreens looks like a potential value trap because future profitability is by no means a guarantee, despite the company's efforts to cut costs. Although it's trading near its book value, investors would be right to demand a discount for the healthcare stock given the risk involved with the business.

Walgreens stock may be cheap, but it's far from a no-brainer buy

Although it may not be easy, if you're still hanging on to Walgreens in your portfolio, now may be as good a time as any to cut your losses. Even under new management, there's no guarantee that it will be in better shape in a year or two. The company's core business is still pharmacy retail, which isn't highly profitable to begin with, and it's not made any easier with competitors like Walmart and Amazon to contend with.

I wouldn't be surprised if Walgreens stock were to continue to fall lower in the months ahead and potentially dip below a $10 billion market cap. It's tempting to think that perhaps this time, with the stock down 40% year to date, it has finally bottomed out, but that's a risky assumption to make.

Even if you are bullish on Walgreens stock at this price point, the safer option would be to sell now and keep an eye on the company to see if its turnaround plan is successful. You might miss out on some gains if it ends up going in the right direction, but you could also avoid further losses in case things don't go according to plan.

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon and Walmart. The Motley Fool has a disclosure policy.

How Low Can Walgreens Boots Alliance Stock Go? | The Motley Fool (2024)

FAQs

How low will WBA stock go? ›

The average price target for Walgreens Boots Alliance is $22.00. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $35.00 ,the lowest forecast is $13.00. The average price target represents 38.02% Increase from the current price of $15.94.

Is Walgreens Boots Alliance a buy or sell? ›

Is Walgreens Boots Alliance stock a Buy, Sell or Hold? Walgreens Boots Alliance stock has received a consensus rating of hold. The average rating score is and is based on 5 buy ratings, 36 hold ratings, and 9 sell ratings.

What are the predictions for Walgreens stock? ›

Based on short-term price targets offered by 14 analysts, the average price target for Walgreens Boots Alliance comes to $21.64. The forecasts range from a low of $13.00 to a high of $35.00. The average price target represents an increase of 40.06% from the last closing price of $15.45.

Is Walgreens stock undervalued? ›

Overall, Walgreens stock looks undervalued at its current levels of around $18, irrespective of the Boots deal. It currently trades at just 5x forward earnings, versus the average of 10x over the last four years.

What is the stock price prediction for WBA in 2025? ›

Walgreens Boots Alliance stock forecast for 2025: $ 14.39 (-7.47%) Walgreens Boots Alliance stock prediction for 2030: $ 9.76 (-37.25%)

What is Walgreens stock price prediction for 2024? ›

Walgreens Boots Stock Price Forecast 2024-2025

The forecasted Walgreens Boots price at the end of 2024 is $18.54 - and the year to year change -29%. The rise from today to year-end: +14%.

What is the outlook for Walgreens? ›

The 13 analysts with 12-month price forecasts for WBA stock have an average target of 24.54, with a low estimate of 13 and a high estimate of 35. The average target predicts an increase of 57.81% from the current stock price of 15.55.

What is the highest Walgreens stock has ever been? ›

Walgreens - 39 Year Stock Price History | WBA
  • The all-time high Walgreens stock closing price was 70.02 on August 05, 2015.
  • The Walgreens 52-week high stock price is 32.89, which is 111.5% above the current share price.
  • The Walgreens 52-week low stock price is 14.62, which is 6% below the current share price.

Who are the largest shareholders of Walgreens Boots Alliance? ›

TOP INSTITUTIONAL HOLDERS

The Vanguard Group, Inc. BlackRock Institutional Trust Company, N.A. Geode Capital Management, L.L.C. Legal & General Investment Management Ltd.

Is WBA a good long-term investment? ›

The Walgreens Boots Alliance stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.

What is the future of Walgreens? ›

Expect a leaner, smaller footprint

One of the things that's likely to happen over the next decade is that Walgreens becomes smaller in size. The company has a lot of physical store locations, but that means a higher level of staffing needs and resources. It also comes with more costs and challenges.

What is the intrinsic value of Walgreens Boots Alliance? ›

As of today (2024-06-09), Walgreens Boots Alliance's Intrinsic Value: Projected FCF is $46.03. The stock price of Walgreens Boots Alliance is $15.84.

Why is Walgreens' market cap so low? ›

The company's core business is still pharmacy retail, which isn't highly profitable to begin with, and it's not made any easier with competitors like Walmart and Amazon to contend with.

Is Pfizer a buy, sell, or hold? ›

Is PFE a Buy, Sell or Hold? Pfizer has a consensus rating of Moderate Buy which is based on 7 buy ratings, 9 hold ratings and 0 sell ratings. What is Pfizer's price target? The average price target for Pfizer is $33.50.

Will Smith and Wesson stock go up? ›

In the upcoming year, Smith & Wesson Brands' earnings are expected to increase by 83%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

Top Articles
Latest Posts
Article information

Author: Barbera Armstrong

Last Updated:

Views: 5987

Rating: 4.9 / 5 (59 voted)

Reviews: 90% of readers found this page helpful

Author information

Name: Barbera Armstrong

Birthday: 1992-09-12

Address: Suite 993 99852 Daugherty Causeway, Ritchiehaven, VT 49630

Phone: +5026838435397

Job: National Engineer

Hobby: Listening to music, Board games, Photography, Ice skating, LARPing, Kite flying, Rugby

Introduction: My name is Barbera Armstrong, I am a lovely, delightful, cooperative, funny, enchanting, vivacious, tender person who loves writing and wants to share my knowledge and understanding with you.